Suppression of atherogenesis by nifedipine in the cholesterol-fed rhesus monkey.

Applied pathology Pub Date : 1989-01-01
T Lichtor, H R Davis, D Vesselinovitch, R W Wissler, S Mullan
{"title":"Suppression of atherogenesis by nifedipine in the cholesterol-fed rhesus monkey.","authors":"T Lichtor,&nbsp;H R Davis,&nbsp;D Vesselinovitch,&nbsp;R W Wissler,&nbsp;S Mullan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Diet-induced atherosclerosis in rhesus monkeys was suppressed in the carotid arteries and thoracic aorta by the calcium antagonist nifedipine given orally for a period of 1 year at a dose of 10 mg b.i.d. The extent of atherosclerosis was determined by quantitative micromorphometric studies. No change in serum blood cholesterol or biochemical composition of the major vessels was detected, but the intimal area and thickness of the atherosclerotic plaques in the carotid arteries of the nifedipine group were markedly less than those found with the control group (p less than 0.05). However, no statistically significant differences were seen in the degree of atherosclerotic involvement of the other major arterial vessels. Although the mechanism is not clear, nifedipine may be useful in the treatment of carotid artery disease.</p>","PeriodicalId":77670,"journal":{"name":"Applied pathology","volume":"7 1","pages":"8-18"},"PeriodicalIF":0.0000,"publicationDate":"1989-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied pathology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Diet-induced atherosclerosis in rhesus monkeys was suppressed in the carotid arteries and thoracic aorta by the calcium antagonist nifedipine given orally for a period of 1 year at a dose of 10 mg b.i.d. The extent of atherosclerosis was determined by quantitative micromorphometric studies. No change in serum blood cholesterol or biochemical composition of the major vessels was detected, but the intimal area and thickness of the atherosclerotic plaques in the carotid arteries of the nifedipine group were markedly less than those found with the control group (p less than 0.05). However, no statistically significant differences were seen in the degree of atherosclerotic involvement of the other major arterial vessels. Although the mechanism is not clear, nifedipine may be useful in the treatment of carotid artery disease.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
硝苯地平对高胆固醇猕猴动脉粥样硬化的抑制作用。
钙拮抗剂硝苯地平口服1年,剂量为10mg / d,可抑制恒河猴颈动脉和胸主动脉的饮食性动脉粥样硬化。动脉粥样硬化的程度通过定量显微形态学研究确定。硝苯地平组大鼠血清血胆固醇及主要血管生化成分未见明显变化,但颈动脉内膜面积及动脉粥样硬化斑块厚度明显小于对照组(p < 0.05)。然而,在其他主要动脉血管的动脉粥样硬化受累程度上没有统计学上的显著差异。虽然机制尚不清楚,硝苯地平可能对治疗颈动脉疾病有用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cervical neoplasia. Soft tissue tumors. Immunocytochemistry of anaplastic carcinoma of thyroid gland. Malignant peripheral nerve sheath tumors and spindle cell sarcomas: an immunohistochemical analysis of multiple markers. Coexpression of cytokeratin and vimentin.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1